95 related articles for article (PubMed ID: 23100616)
21. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.
Gjoerup J; Hilberg O; Bendstrup E
Respirology; 2012 Aug; 17(6):927-32. PubMed ID: 22564014
[TBL] [Abstract][Full Text] [Related]
22. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
23. Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function.
Accurso FJ; Moss RB; Wilmott RW; Anbar RD; Schaberg AE; Durham TA; Ramsey BW;
Am J Respir Crit Care Med; 2011 Mar; 183(5):627-34. PubMed ID: 21169471
[TBL] [Abstract][Full Text] [Related]
24. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial.
Gupta S; Ahmed F; Lodha R; Gupta YK; Kabra SK
J Trop Pediatr; 2012 Oct; 58(5):375-81. PubMed ID: 22374985
[TBL] [Abstract][Full Text] [Related]
25. Inhaled dry powder mannitol: a solution for cystic fibrosis.
Trapnell BC
Am J Respir Crit Care Med; 2012 Mar; 185(6):596-8. PubMed ID: 22422901
[No Abstract] [Full Text] [Related]
26. Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine.
Elborn JS; Henig NR
Expert Opin Pharmacother; 2010 Jun; 11(8):1373-85. PubMed ID: 20426707
[TBL] [Abstract][Full Text] [Related]
27. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
Dodd JD; Barry SC; Daly LE; Gallagher CG
J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
[TBL] [Abstract][Full Text] [Related]
28. Value of inhaled antibiotics in cystic fibrosis patients.
Wunderlich P; Paul KD; Wehner J
Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
[TBL] [Abstract][Full Text] [Related]
29. Hypertonic saline and PEP: is it worth a try?
O'Malley CA
Respir Care; 2011 Jun; 56(6):886-7. PubMed ID: 21679498
[No Abstract] [Full Text] [Related]
30. [Use of inhaled tobramycin in patients with cystic fibrosis].
Chermenskiĭ AG; Gembitskaia TE
Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
[TBL] [Abstract][Full Text] [Related]
31. Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis.
O'Connell OJ; O'Farrell C; Harrison MJ; Eustace JA; Henry MT; Plant BJ
Respir Care; 2011 Jun; 56(6):771-5. PubMed ID: 21333079
[TBL] [Abstract][Full Text] [Related]
32. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
Subbarao P; Balkovec S; Solomon M; Ratjen F
Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
[TBL] [Abstract][Full Text] [Related]
33. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis.
Balfour-Lynn IM; Lees B; Hall P; Phillips G; Khan M; Flather M; Elborn JS;
Am J Respir Crit Care Med; 2006 Jun; 173(12):1356-62. PubMed ID: 16556691
[TBL] [Abstract][Full Text] [Related]
34. [The effect of ipratropium bromide on lung function in patients with cystic fibrosis].
Wiebicke W; Poynter A; Montgomery M; Pagtakhan R
Pneumologie; 1990 Feb; 44 Suppl 1():277-8. PubMed ID: 2142293
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone and cystic fibrosis: good for more than growth?
Bucuvalas JC; Chernausek SD
J Pediatr; 2001 Nov; 139(5):616-8. PubMed ID: 11713433
[No Abstract] [Full Text] [Related]
36. Oral acetylcysteine in cystic fibrosis. A co-operative study.
Götz M; Kraemer R; Kerrebijn KF; Popow C
Eur J Respir Dis Suppl; 1980; 111():122-6. PubMed ID: 7011832
[No Abstract] [Full Text] [Related]
37. [Antibiotic inhalation in cystic fibrosis. A review of the literature].
Steinkamp G
Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843
[TBL] [Abstract][Full Text] [Related]
38. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: poor adherence and the need to address it.
Duff AJ; Latchford GJ
J Cyst Fibros; 2010 Dec; 9(6):455-6. PubMed ID: 20840889
[No Abstract] [Full Text] [Related]
39. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus.
Heijerman H; Westerman E; Conway S; Touw D; Döring G;
J Cyst Fibros; 2009 Sep; 8(5):295-315. PubMed ID: 19559658
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary mechanics in asthma and cystic fibrosis.
Zapletal A; Motoyama EK; Gibson LE; Bouhuys A
Pediatrics; 1971 Jul; 48(1):64-72. PubMed ID: 5561883
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
